173 related articles for article (PubMed ID: 2549584)
1. [Ki-1 non-Hodgkin's lymphoma. A multihospital study of 21 cases].
Rivas C; Obeso G; Piris M; Castrillo JM; Bellas C; Acevedo A; Martín C; Campo E; Gamallo C; Font M
Rev Clin Esp; 1989 Mar; 184(5):238-44. PubMed ID: 2549584
[TBL] [Abstract][Full Text] [Related]
2. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
3. CD30 expression in non-Hodgkin's lymphoma.
Piris M; Brown DC; Gatter KC; Mason DY
Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
[TBL] [Abstract][Full Text] [Related]
4. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
Offit K; Ladanyi M; Gangi MD; Ebrahim SA; Filippa D; Chaganti RS
Leukemia; 1990 Sep; 4(9):625-30. PubMed ID: 2168505
[TBL] [Abstract][Full Text] [Related]
5. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.
Schwarting R; Gerdes J; Dürkop H; Falini B; Pileri S; Stein H
Blood; 1989 Oct; 74(5):1678-89. PubMed ID: 2477085
[TBL] [Abstract][Full Text] [Related]
6. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Tsurumi H; Takahashi T; Moriwaki H; Muto Y
Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
8. [Definition of malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in children].
Bucsky P; Feller AC; Beck JD; Gadner H; Heitger A; Ludwig WD; Reiter A; Riehm H
Klin Padiatr; 1989; 201(4):233-6. PubMed ID: 2550697
[TBL] [Abstract][Full Text] [Related]
9. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
Andreesen R; Brugger W; Löhr GW; Bross KJ
Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
[TBL] [Abstract][Full Text] [Related]
10. Immunologic approaches to the classification of non-Hodgkin's lymphomas.
Grogan TM; Spier CM; Richter LC; Rangel CS
Cancer Treat Res; 1988; 38():31-148. PubMed ID: 2908600
[No Abstract] [Full Text] [Related]
11. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35).
Bitter MA; Franklin WA; Larson RA; McKeithan TW; Rubin CM; Le Beau MM; Stephens JK; Vardiman JW
Am J Surg Pathol; 1990 Apr; 14(4):305-16. PubMed ID: 2157342
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of 26 cases of Ki-1 lymphomas: morphoimmunologic correlation.
Rivas C; Piris MA; Gamallo C; Barat A; Echezarreta G; Oliva H; Sarasa JL; Rivas F; Renedo G; Martin C
Ultrastruct Pathol; 1990; 14(5):381-97. PubMed ID: 2174195
[TBL] [Abstract][Full Text] [Related]
14. Genotypic analysis of large cell lymphomas which express the Ki-1 antigen.
O'Connor NT; Stein H; Gatter KC; Wainscoat JS; Crick J; Al Saati T; Falini B; Delsol G; Mason DY
Histopathology; 1987 Jul; 11(7):733-40. PubMed ID: 3040565
[TBL] [Abstract][Full Text] [Related]
15. Ki-1-positive non-Hodgkin's lymphomas. An immunophenotypic, ultrastructural, and morphometric study.
Burns BF; Dardick I
Am J Clin Pathol; 1990 Mar; 93(3):327-32. PubMed ID: 2155526
[TBL] [Abstract][Full Text] [Related]
16. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
Smith JL; Jones DB; Bell AJ; Wright DH
Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes.
van Dongen JJ; Adriaansen HJ; Hooijkaas H
Neth J Med; 1988 Dec; 33(5-6):298-314. PubMed ID: 3265488
[No Abstract] [Full Text] [Related]
18. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas.
Ebrahim SA; Ladanyi M; Desai SB; Offit K; Jhanwar SC; Filippa DA; Lieberman PH; Chaganti RS
Genes Chromosomes Cancer; 1990 May; 2(1):27-35. PubMed ID: 2177640
[TBL] [Abstract][Full Text] [Related]
19. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.
Herbst H; Tippelmann G; Anagnostopoulos I; Gerdes J; Schwarting R; Boehm T; Pileri S; Jones DB; Stein H
Leuk Res; 1989; 13(2):103-16. PubMed ID: 2538681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
